Why organise by sector rather than by product?

Because the same capability answers a different question in each. Analytics means cost per episode to a provider, loss ratio to an insurer and launch uptake to a pharmaceutical company. Presenting the product without the sector question leaves the buyer to do the translation.

Is the underlying technology the same?

Largely yes, and that is deliberate. One data and AI platform serves all four, which is what makes the cross-sector cases work at all — a payer and a provider reading the same transaction, or a manufacturer seeing dispensing data that originated in a pharmacy.

Which sector does NANO start from?

Historically from the provider and payer sides, because that is where claims and clinical data meet. The pharmaceutical and life sciences work builds on the same data foundation rather than on a separate platform.

Can one organisation sit in two sectors?

Frequently, and integrated health systems usually do. An organisation that both delivers care and carries risk needs the provider and payer capabilities to reconcile, which is easier when they were never separate systems.

Where should a sector evaluation start?

With the measure that sector is held to, because that determines which capability matters first. Starting from a product demonstration tends to produce a good meeting and no decision.

Featured Sectors

Transforming healthcare by adopting artificial intelligence solutions to cut operational
costs, boost sales, and improve service efficiency

Healthcare Providers

We offer medical digital solutions for all types of health providers to achieve optimal patient care and take healthcare to a new level of efficiency.

Medical Insurance,
Medical Service &
Managed Care

Discover our digital insurance solutions that trigger managing operations between health facilities, patients, and payers in an organized and efficient atmosphere.

Pharmaceutical &
Related Segments

With our pharmaceutical data analytics systems, keep your human data accessible, organized, and beneficial for research. Trust our pharma data intelligence approach.

Life Sciences Tools &
Services

Check our IT solutions that make the pharma world a better place. Our systems and applications combine technology and artificial intelligence. Browse for more.

How this works with the rest of the suite

NANO EMR
The provider sector starts at the record, because every other provider capability reads from it.
NANO IMS
The insurance sector starts at the policy, member and claim record held in one place.
NANO Rx Insight
The pharmaceutical sector starts with what is actually being prescribed.
NANO IDDK
Drug knowledge is the reference layer all three of the medicine-facing sectors depend on.

Frequently asked questions

Why organise by sector rather than by product?: Because the same capability answers a different question in each. Analytics means cost per episode to a provider, loss ratio to an insurer and launch uptake to a pharmaceutical company. Presenting the product without the sector question leaves the buyer to do the translation.
Is the underlying technology the same?: Largely yes, and that is deliberate. One data and AI platform serves all four, which is what makes the cross-sector cases work at all — a payer and a provider reading the same transaction, or a manufacturer seeing dispensing data that originated in a pharmacy.
Which sector does NANO start from?: Historically from the provider and payer sides, because that is where claims and clinical data meet. The pharmaceutical and life sciences work builds on the same data foundation rather than on a separate platform.
Can one organisation sit in two sectors?: Frequently, and integrated health systems usually do. An organisation that both delivers care and carries risk needs the provider and payer capabilities to reconcile, which is easier when they were never separate systems.
Where should a sector evaluation start?: With the measure that sector is held to, because that determines which capability matters first. Starting from a product demonstration tends to produce a good meeting and no decision.